To evaluate the biological role of both NF-κB pathway activities, we correlated the nuclear localization of p65 or RelB with clinical parameters and risk of biochemical recurrence to better undrstand the potential role of the NF-κB pathway crosstalk in prostate cancer progression. Here, NFKB1 is linked to prostate carcinoma.